PDF herunterladen
Nervenheilkunde 2013; 32(06): 370-374
DOI: 10.1055/s-0038-1628514
Rehabilitation in der Psychiatrie
Schattauer GmbH

Kognitive Remediation

Rehabilitation von Menschen mit Erkrankungen aus dem schizophrenen FormenkreisCognitive remediaton improves response to psychiatric rehabilitation in persons with schizophrenic spectrum disorders
M. Weisbrod
1   Klinik für allgemeine Psychiatrie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Heidelberg
2   Abteilung für Psychiatrie und Psychotherapie, SRH Klinikum, Karlsbad-Langensteinbach
,
S. Aschenbrenner
2   Abteilung für Psychiatrie und Psychotherapie, SRH Klinikum, Karlsbad-Langensteinbach
,
U. Pfüller
2   Abteilung für Psychiatrie und Psychotherapie, SRH Klinikum, Karlsbad-Langensteinbach
,
S. Kaiser
3   Psychiatrische Universitätsklinik Zürich
,
D. Roesch-Ely
1   Klinik für allgemeine Psychiatrie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Heidelberg
› Institutsangaben
Weitere Informationen

Publikationsverlauf

eingegangen am: 10. Januar 2013

angenommen am: 09. Februar 2013

Publikationsdatum:
24. Januar 2018 (online)

    Lizenzen und Reprints

Zusammenfassung

Rehabilitation von Menschen mit schizophrenen Psychosen zielt auf die Erhaltung und/oder die Verbesserung komplexer Alltagsfunktionen wie Wohnen, Arbeit und Sozialbeziehungen ab. Kognitive Funktionen, die bei der überwiegenden Mehrheit der Erkrankten erheblich beeinträchtigt sind, haben sich als die besten Prädiktoren für die Alltagsfunktionalität erwiesen. Die Behandlung kognitiver Defizite bietet daher einen rationalen Ansatz für Interventionen im Rahmen der psychiatrischen Rehabilitation. Der vorliegende Beitrag fasst die aktuelle Evidenz zur Behandlung kognitiver Störungen bei Schizophrenien zusammen und bewertet ihre Bedeutung für die Erreichung psychiatrischer Rehabilitationsziele. Die Behandlung kognitiver Defizite bei an Schizophrenie erkrankten Menschen ist möglich und im Sinne der zentralen Rehabilitationsziele erfolgreich. Kognitive Remediation sollte einen zentralen Platz in der psychiatrischen Rehabilitation einnehmen.

Summary

Psychiatric rehabilitation for persons with schizophrenia aims at preservation and improvement of psychosocial functions in areas such as work, social relationship and independent living. Cognitive functioning is impaired in schizophrenic patients and was shown to be a robust predictor of psychosocial functioning. This qualifies cognitive functioning as an appropriate and rational target for rehabilitative interventions. This article summarizes evidence concerning the therapy of cognitive deficits in schizophrenia and describes its impact on psychiatric rehabilitation. Cognitive remediation therapy produces moderate improvements in cognitive performance and, when combined with functional training and embedded in comprehensive psychiatric rehabilitation, also enhances functional outcomes. We conclude that therapy of cognitive functioning provides an important tool for psychiatric rehabilitation.

Schlüsselwörter

Schizophrenie - Rehabilitation - Kognition - kognitive Remediation

Keywords

Schizophrenia - rehabilitation - vocational - cognition - cognitive remediation
 

  • Literatur

  • 1 Ramsay CE. et al. Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis. Psychiatry Res 2011; 189: 344-8.
    CrossrefPubMedGoogle Scholar
  • 2 Salize HJKR. Gesundheitsökonomie in der Psychiatrie – Konzepte, Methoden, Analysen. Stuttgart: Kohlhammer 2010
    PubMedGoogle Scholar
  • 3 Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 1996; 321-30.
    PubMedGoogle Scholar
  • 4 Keefe RS. et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006; 153: 2033-46.
    Google Scholar
  • 5 Kraepelin E. Psychiatrie. Leipzig: Barth 1909
    PubMedGoogle Scholar
  • 6 Bleuler E. Dementia Praecox oder die Gruppe der Schizophrenien. 1. Aufl. Leipzig: Deuticke 1911
    PubMedGoogle Scholar
  • 7 Watson CG. et al. Differentiation of organics from schizophrenics at two chronicity levels by use of the Reitan-Halstead Organic Test Battery. Journal of Consulting and Clinical Psychology 1968; 32: 679-84.
    CrossrefPubMedGoogle Scholar
  • 8 Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426-45.
    CrossrefPubMedGoogle Scholar
  • 9 Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004; 72: 21-8.
    CrossrefPubMedGoogle Scholar
  • 10 Hughes C. et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 2003; 59: 137-46.
    CrossrefPubMedGoogle Scholar
  • 11 Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984; 10: 160-203.
    CrossrefPubMedGoogle Scholar
  • 12 Nuechterlein KH. Childhood precursors of adult schizophrenia. J Child Psychol Psychiatry 1986; 133-44.
    PubMedGoogle Scholar
  • 13 Cornblatt BA. et al. Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. Br J Psychiatry 1992; Suppl. 27: 59-64.
    Google Scholar
  • 14 Bilder R. et al. Neuropsychological deficits in the early course of first episode schizophrenia. Schizophr Res 1991; 198-9.
    PubMedGoogle Scholar
  • 15 Heaton RK. et al. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001; 05: 24-32.
    Google Scholar
  • 16 Pfüller U. et al. Behandlung kognitiver Defizite bei Schizophrenie. Teil I: Diagnostik und psychologische Verfahren. Nervenarzt 2010; 81: 556-63.
    CrossrefPubMedGoogle Scholar
  • 17 Roesch-Ely D. et al. Behandlung kognitiver Defizite bei Schizophrenie. Teil II: Pharmakologische Strategien. Nervenarzt 2010; 81: 564-76.
    CrossrefPubMedGoogle Scholar
  • 18 Bowie CR. et al. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional ompetence, and real-world behavior. Am J Psychiatry 2012; 769: 710-8.
    Google Scholar
  • 19 Mishara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry 2004; 55: 1013-22.
    CrossrefPubMedGoogle Scholar
  • 20 Medalia A, Gold J, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 1988; 03: 249-71.
    CrossrefGoogle Scholar
  • 21 Purdon SE. et al. Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology 2003; 169: 390-7.
    CrossrefPubMedGoogle Scholar
  • 22 Blyler C RGJM. Cognitive effects of typical antipsychotic treatment: another look. Sharma THP. (ed.). Oxford: Oxford University Press; 2000
    Google Scholar
  • 23 Strauss ME, Reynolds KS, Jayaram G, Tune LE. Effects of anticholinergic medication on memory in schizophrenia. Schizophr Res 1990; 03: 127-9.
    CrossrefPubMedGoogle Scholar
  • 24 Woodward ND. et al. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr Res 2007; 89: 211-24.
    CrossrefPubMedGoogle Scholar
  • 25 Hagger C. et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993; 34: 702-12.
    CrossrefPubMedGoogle Scholar
  • 26 Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994; 13: 133-44.
    CrossrefPubMedGoogle Scholar
  • 27 Potkin SG, Fleming K, Jin Y, Gulasekaram B. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J Clin Psychopharmacol 2001; 21: 479-83.
    CrossrefPubMedGoogle Scholar
  • 28 Weickert TW. et al. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology 2003; 28: 1491-500.
    CrossrefPubMedGoogle Scholar
  • 29 Keefe RS. et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007; 64: 633-47.
    CrossrefPubMedGoogle Scholar
  • 30 Barnett JH. et al. Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling. BMC Psychiatry 2007; 07: 16.
    CrossrefPubMedGoogle Scholar
  • 31 Goldberg TE. et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch Gen Psychiatry 2007; 64: 1115-22.
    CrossrefPubMedGoogle Scholar
  • 32 Roesch-Ely D. et al. Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology 2005; 178: 420-30.
    CrossrefPubMedGoogle Scholar
  • 33 Roesch-Ely D. et al. Dopaminergic modulation of semantic priming in healthy volunteers. Biol Psychiatry 2006; 60: 604-11.
    CrossrefPubMedGoogle Scholar
  • 34 Wykes T. et al. Schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168: 472-85.
    CrossrefPubMedGoogle Scholar
  • 35 Dickinson D. et al. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. Am J Psychiatry 2010; 167: 170-180.
    CrossrefPubMedGoogle Scholar
  • 36 Goldberg T. et al. Further evidence for dementia of the prefrontal type in schizophrenia. A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008-14.
    CrossrefPubMedGoogle Scholar
  • 37 Suslow T, Schonauer K, Arolt V. Attention training in the cognitive rehabilitation of schizophrenic patients: a review of efficacy studies. Acta Psychiatr Scand 2001; 103: 15-23.
    CrossrefPubMedGoogle Scholar
  • 38 Rodewald K. et al. Planning and problem-solving training for patients with schizophrenia: a randomized controlled trial. BMC Psychiatry 2011; 11: 73.
    CrossrefPubMedGoogle Scholar
  • 39 Olbrich R. Psychologische Verfahren zur Reduktion kognitiver Defizite. Fortschr Neurol Psychiatr 1999; 67: 74-6.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 40 Sartory G. et al. Computerized cognitive remediation improves verbal learning and processing speed in schizophrenia. Schizophr Res 2005; 75: 219-23.
    CrossrefPubMedGoogle Scholar
  • 41 Wexler BE. et al. Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises. Am J Psychiatry 2000; 15: 1694-7.
    Google Scholar
  • 42 Bor J. et al. How can cognitive remediation therapy modulate brain activations in schizophrenia? An fMRI study. Psychiatry Res 2011; 192: 160-6.
    CrossrefPubMedGoogle Scholar
  • 43 McGurk SR, Mueser KT, Pascaris A. Cognitive training and supported employment for persons with severe mental illness: one-year results from a randomized controlled trial. Schizophr Bull 2005; 31: 898-909.
    CrossrefPubMedGoogle Scholar
  • 44 McGurk SR. et al. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry 2007; 164: 437-41.
    CrossrefPubMedGoogle Scholar
  • 45 Vauth R. et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophr Bull 2005; 31: 55-66.
    CrossrefPubMedGoogle Scholar
  • 46 McGurk SR. et al. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007; 164: 1791-802.
    CrossrefPubMedGoogle Scholar
  • 47 Reeder C, Newton E, Frangou S, Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr Bull 2004; 30: 87-100.
    CrossrefPubMedGoogle Scholar
  • 48 Müller DR, Roder V, Brenner HD. Effektivität des Integrierten Psychologischen Therapieprogramms für schizophren Erkrankte. Nervenarzt 2007; 78: 62-73.
    CrossrefPubMedGoogle Scholar
  • 49 Roder V, Mueller DR, Schmidt SJ. Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull 2011; 37 (Suppl. 02) 71-9.
    CrossrefPubMedGoogle Scholar
  • 50 Salize HJ. Die Psychiatrische Rehabilitation wird zu einem der Zukunftsthemen der Psychiatrie – Pro & Kontra. Psychiatr Prax 2012; 39: 317-8.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 51 Watzke et al. Dynamisch kognitives Testen in der Auswahl optimaler rehabilitativer Versorgungsangebote. Nervenheilkunde 2013; 32: 363-369.
    Artikel in Thieme ConnectGoogle Scholar